NEW YORK (GenomeWeb) – Great Basin Scientific today reported that its first quarter revenues rose 14 percent year over year, driven primarily by an 82 percent increase in sales of its Group B Strep assay. 

For the three months ended March 31, the Salt Lake City-based firm reported revenue of $830,777, up from $731,422 in the first quarter of 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.